Patient and Parent Preferences for an On-Body Automated Insulin Delivery System



Status:Recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:8 - 25
Updated:1/11/2019
Start Date:August 23, 2018
End Date:April 2019
Contact:Lori Laffel, MD, MPH
Email:lori.laffel@joslin.harvard.edu
Phone:617-732-2603

Use our guide to learn which trials are right for you!

The goal of this study is to learn more about patient and family preferences regarding use of
advanced diabetes technologies. Young persons with type 1 diabetes (ages 8-25) and parents of
young persons with type 1 diabetes will complete one study visit involving a semi-structured
interview and surveys. The results of the study will be used to assist in the design of a new
automated insulin delivery system.

Type 1 diabetes remains the most common chronic disease of childhood and affects millions of
children and adults globally. The minority of persons with type 1 diabetes achieve the
recommended glycemic targets. Currently approved and unapproved automated insulin delivery
systems require patients to carry and wear multiple devices (pumps, tubing, blood glucose
meters, mobile devices, etc.). There is a need to design automated insulin delivery systems
that reduce the burden of diabetes management for young persons and their families in an
effort to improve glycemic control as well as other biomedical and psychosocial outcomes.

The purpose of this study is to conduct separate semi-structured interviews with young
persons with type 1 diabetes and parents of youth with type 1 diabetes (not necessarily the
parents of the youth participants) regarding their preferences for an automated, on-body
insulin delivery system. Youth and parents will also complete short surveys related to
perceived burden of diabetes self-care, quality of life, acceptance of diabetes, and worries
about hypoglycemia. The feedback received from the interviews and surveys will help inform
the design of a new on-body automated insulin delivery system.

Inclusion Criteria:

- Young persons (ages 8-25 years) with type 1 diabetes for 1 year or longer

- Parents of young persons with type 1 diabetes

Exclusion Criteria:
We found this trial at
2
sites
333 Cedar St
New Haven, Connecticut 06504
(203) 432-4771
Principal Investigator: Stuart Weinzimer, MD
Phone: 203-737-3595
Yale University School of Medicine Founded in 1810, the Yale School of Medicine is a...
?
mi
from
New Haven, CT
Click here to add this to my saved trials
One Joslin Place
Boston, Massachusetts 02215
617-309-2400
Principal Investigator: Lori Laffel, MD, MPH
Phone: 617-309-4477
Joslin Diabetes Center Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes...
?
mi
from
Boston, MA
Click here to add this to my saved trials